Dermatology Search
Dermatology Dermatology
melanoma
MELANOMA
Melanoma is a skin neoplasm that originates from malignant transformation of melanocytes.
It commonly occurs in the extremities of women and on trunk or head and neck in men.
Metastases are via lymphatic and hematogenous routes.
Drug Information

Indication: Unresectable or metastatic melanoma. Advanced non-small cell lung carcinoma (NSCLC) whose tumors express PD-L1...

Indication: Newly diagnosed glioblastoma multiforme concomitantly w/ radiotherapy & adjuvant treatment. Malignant glio...

Indication: Tab: Multiple myeloma, advanced ovarian adenocarcinoma, breast carcinoma, polycythaemia rubra vera. Inj: Local...

Indication: Monotherapy or in combination w/ other chemotherapeutic agents for metastatic non-seminomatous germ cell carci...

Indication: Monotherapy or combination therapy for palliative treatment of metastatic non-seminomatous germ cell carcinoma...

Indication: Metastatic malignant melanoma & various sarcomas.

Indication: Acute leukemia. In combination w/ other oncolytic agents in Hodgkin's disease, non-Hodgkin's malignant lymphom...

Indication: Breast, gastric, ovarian & small cell lung cancer; non-Hodgkin's lymphoma; advanced/metastatic soft tissue...

Gliadel
carmustine + polifeprosan

Indication: Adjunct to surgery & radiation in newly-diagnosed high-grade malignant glioma & recurrent glioblastoma...

Indication: Breast, gastric, ovarian, small cell lung & superficial bladder (Tis, Ta) cancer, Non-Hodgkin's lymphoma, ...

1  /  2
1  /  2
Editor's Recommendations
Most Read Articles
Prolonged oestrogen exposure in older women yields cognitive benefits
4 days ago
Older women with longer endogenous oestrogen exposure and hormone therapy use are at much higher odds of having favourable cognitive status in late life, a recent study suggests.
Rivaroxaban monotherapy safe, effective in AF, stable CAD patients
2 days ago
In patients with atrial fibrillation (AF) and stable coronary artery disease (CAD), rivaroxaban monotherapy is noninferior to combination treatment with an antiplatelet therapy in terms of cutting the risk of cardiovascular events and mortality, according to data from the AFIRE trial.
Omega-3, vitamin D no help for kidney function: Time to shift attention
Elvira Manzano, 3 days ago
Supplementation with omega-3 fatty acids or vitamin D3 for up to 5 years has no effect on kidney function in adults with type 2 diabetes (T2D), the VITAL-DKD* ancillary study has shown.
COOL-AF data point to unmet need for stroke prevention in NVAF patients in Thailand
Jairia Dela Cruz, 18 hours ago
Many patients with nonvalvular atrial fibrillation (NVAF) in Thailand use anticoagulants, but the uptake of nonvitamin-K oral anticoagulants remains suboptimal despite showing an upward trend, according to data from the COOL-AF registry presented at the European Society of Cardioloy (ESC) Asia Congress 2019 with APSC and AFC.